CLINICAL_TRIALS
ClinicalTrials.gov record update
A First-in-Human, Phase 1/2, Dose Escalation Study of BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05120271
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:52.395594+00:00
- Published At
- 2025-12-05T00:00:00+00:00
- Record Updated At
- 2025-12-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Hepatocellular Carcinoma", "Squamous Cell Carcinoma of the Lung", "Merkel Cell Carcinoma", "Myxoid/Round Cell Liposarcoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-05"- protocolSection.identificationModule.nctId
"NCT05120271"- protocolSection.identificationModule.officialTitle
"A First-in-Human, Phase 1/2, Dose Escalation Study of BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.